Stereological and Flow Cytometry Characterization of Leukocyte Subpopulations in Models of Transient or Permanent Cerebral Ischemia
December 28th, 2014
19.6K views
Brain myeloid cells characterization following stroke can be performed by stereology using the optical fractionator method, or by a flow cytometric analysis of brain leukocytes suspensions. Both are useful techniques to perform an accurate phenotypical distinction of the main myeloid cell subsets found in the ischemic brain.
Overview
This study characterizes myeloid cell subsets in the ischemic brain using two methodologies: stereology with the optical fractionator method and flow cytometry. Both techniques enable accurate phenotypical distinction of myeloid cells following stroke.
Key Study Components
Area of Science
- Neuroscience
- Cell Biology
- Stroke Research
Background
- Myeloid cells play a crucial role in the immune response following cerebral ischemia.
- Characterization of these cells can provide insights into their functions in brain injury.
- Existing methods for studying myeloid cells have limitations, including high mortality rates in animal models.
- Improved methodologies are necessary for better understanding the roles of these cells in stroke.
Purpose of Study
- To characterize mouse myeloid cell subsets in the ischemic brain.
- To compare the effectiveness of stereology and flow cytometry in quantifying myeloid cells.
- To minimize animal usage while maximizing data quality.
Methods Used
- Induction of cerebral ischemia through occlusion of the common carotid artery and middle cerebral artery.
- Immunostaining of brain sections for myeloid cell identification.
- Quantification of infiltrated cells using the optical fractionator method.
- Isolation of myeloid cells from brain tissue for flow cytometric analysis.
Main Results
- Successful characterization of myeloid cell subsets using both methodologies.
- Flow cytometry provided detailed qualitative data on cell phenotypes.
- The optical fractionator method allowed for accurate quantification of cell populations.
- Lower mortality rates were observed with the described ischemia model compared to traditional methods.
Conclusions
- Both stereology and flow cytometry are effective for studying myeloid cells in stroke.
- The methodologies can help answer critical questions regarding immune responses in brain injury.
- These techniques may enhance our understanding of the roles of myeloid cells in ischemic conditions.
Frequently Asked Questions
What are myeloid cells?
Myeloid cells are a type of immune cell that includes macrophages and neutrophils, playing key roles in the body's response to injury and infection.
How does the optical fractionator method work?
The optical fractionator method involves counting cells in a defined volume of tissue to estimate the total number of cells in a larger area.
What is the significance of studying myeloid cells in stroke?
Understanding myeloid cell behavior and function can provide insights into the mechanisms of brain injury and recovery following stroke.
Why is flow cytometry used in this study?
Flow cytometry allows for the detailed analysis of cell populations based on specific markers, providing qualitative and quantitative data.
What advantages does this study's model offer?
The model used in this study has lower mortality rates, reducing the number of animals needed while still providing reliable data.
How can these findings impact stroke research?
The findings can inform therapeutic strategies by elucidating the roles of myeloid cells in stroke pathology and recovery.
Executive Industry Relevance
Accurate quantification and phenotypic characterization of infiltrating myeloid cells in cerebral ischemia models are critical for de-risking neuroinflammatory target hypotheses. Dual-method validation via stereology and flow cytometry enhances predictive confidence in target validation by providing orthogonal data on cell number and phenotype. This supports informed go/no-go decisions in early discovery by reducing mechanistic ambiguity in stroke pathophysiology.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of therapeutic hypotheses regarding myeloid cell involvement in brain injury after stroke.
- Operational Value: Provides biological de-risking through precise quantification of neutrophil and monocyte infiltration using the optical fractionator method.
- Predictive Value: Supports portfolio triage by delivering phenotypic and functional insights into CD11b+/CD45high leukocyte subsets via multiparametric flow cytometry.
Screening & Assay Development
- Scientific Value: Generates validated leukocyte suspensions from ischemic cortex for reproducible immunophenotyping.
- Operational Value: Standardizes sample preparation via mechanical dissociation and myelin removal to ensure assay consistency.
- Scalability: Enables platform reuse for screening immunomodulatory compounds in stroke models.
Translational & Preclinical Research
- Scientific Value: Maintains disease relevance by modeling cortical infarcts with high reproducibility and low mortality.
- Operational Value: Ensures translational continuity from discovery to preclinical validation through standardized infarct quantification by the Cavalieri method.
- Risk Mitigation: Informs risk-adjusted advancement decisions by correlating neutrophil infiltration with infarct size.
Pipeline & Workflow Integration
The method integrates into the discovery continuum from target validation through lead identification to preclinical efficacy testing in stroke models.
- Discovery Biology: Supports hypothesis testing and pathway clarification by quantifying myeloid cell subsets in defined brain regions.
- Screening: Delivers assay readiness and quantitative outputs via flow cytometric analysis of CD11b+/CD45high/Ly6G+ neutrophils and inflammatory monocytes.
- Analytics: Provides statistical outputs including cell counts and phenotypic frequencies that enable cross-condition comparison.
- Translational Research: Connects to preclinical continuity through infarct volume estimation and leukocyte yield from lesional hemispheres.
- Enterprise Reuse: Establishes a reusable capability for immunophenotyping in multiple cerebral ischemia models.
Operational & Enterprise Impact
- Scientific Value: Predictive confidence in target validation through dual-method characterization of myeloid cell number and phenotype.
- Operational Value: Standardization and reproducibility via systematic random sampling (optical fractionator) and standardized flow cytometry gating.
- Strategic Value: Better go/no-go decisions by reducing late-stage biological risk in neuroinflammatory programs.
- Portfolio Impact: Risk-adjusted prioritization based on quantitative infarct and leukocyte infiltration data.
Implementation Considerations
- Requires expertise in neurosurgical techniques, immunofluorescence staining, and stereological quantification.
- Dependent on microtome, fluorescence microscope with stereo investigator software, and flow cytometer with appropriate laser configurations.
- Necessitates cross-team standardization between histology and immunology teams for correlated analysis.
- Adaptation considerations include adjusting sampling fractions and contour definitions for different infarct models.
- Practical limitations include tissue processing time and the need for fresh tissue isolation to preserve leukocyte viability for flow cytometry.
Biopharma FAQs
Why does optical fractionator quantification matter for target validation in stroke models?
The optical fractionator method provides unbiased, systematic random sampling-based estimates of total neutrophil and monocyte numbers in the infarcted cortex. This enables rigorous hypothesis testing regarding the role of specific myeloid subsets in brain injury. Accurate cell counting supports target validation by reducing variability and increasing statistical power in preclinical studies.
How does isolation of brain leukocytes enable independent variable isolation in the discovery pipeline?
Mechanical dissociation of ischemic brain tissue followed by myelin removal yields a purified leukocyte suspension, isolating the variable of immune cell infiltration from confounding factors like erythrocytes and debris. This purified sample allows researchers to attribute flow cytometric signals specifically to microglia, monocytes, and neutrophils. Isolating this variable is essential for attributing phenotypic changes to experimental interventions in stroke models.
What quantitative dependent variable measurements does flow cytometry enable for myeloid cell characterization?
Flow cytometry enables quantitative measurement of leukocyte subset frequencies, including CD11b+/CD45high/Ly6G+ neutrophils and CD11b+/CD45high/Ly6G- inflammatory monocytes, as a percentage of total live cells. It also provides mean fluorescence intensity data for activation markers, supporting functional phenotyping. These measurements serve as dependent variables to assess the impact of genetic or pharmacological interventions on immune cell recruitment and activation.
Why do replication requirements matter for cross-functional collaboration in myeloid cell analysis?
Replication using both stereology and flow cytometry ensures orthogonal validation of myeloid cell infiltration, increasing confidence in results across histology and immunology teams. Consistent infarct volumes via the Cavalieri method and reproducible leukocyte yields support reliable data sharing between groups. This reduces misalignment in target validation meetings and strengthens go/no-go decision-making in multidisciplinary stroke research projects.
What statistical analysis capabilities are required before implementing stereology and flow cytometry in stroke studies?
Implementation requires capability for estimating total cell numbers with precision using the optical fractionator, including calculation of coefficients of error. For flow cytometry, statistical comparison of subset frequencies and marker expression across groups necessitates tools for analyzing percentage data and median fluorescence intensity. Both methods benefit from power analysis to determine adequate animal numbers based on expected effect sizes and variability in leukocyte infiltration.
Chapters in this video
0:05
Title
2:20
Common Carotid Artery and Distal Middle Cerebral Artery Occlusion by Ligation
3:56
Perfusion and Sectioning of Brain Tissue
5:36
Stereological Quantification of Infiltrated Neutrophils After Cerebral Ischemia by Optical Fractionation
7:23
Brain Dissociation and Single Cell Suspension Preparation
9:41
Results: Representative Flow Cytometric Analysis of Brain Leukocytes Obtained from Naïve, Sham and Ischemic Mice
11:44
Conclusion
